Search for: "Gibbs v. State of North Carolina"
Results 1 - 11
of 11
Sorted by Relevance
|
Sort by Date
14 Nov 2023, 9:22 am
The Rule was amended in 2011, adopting the federal standard for the admission of expert testimony, and making North Carolina a Daubert state. [read post]
21 Jun 2023, 6:28 am
Supreme Court (June 16, 2023) appeared first on North Carolina Criminal Law. [read post]
3 Apr 2019, 11:06 am
United States Department of Interior (Gaming - Tribal Service Area)Gibbs v. [read post]
3 Apr 2019, 11:06 am
United States Department of Interior (Gaming - Tribal Service Area)Gibbs v. [read post]
10 Mar 2010, 6:38 am
Retired Justice Sandra Day O’Connor carried her campaign to end judicial elections to Elon University School of Law in Greensboro, North Carolina, reports the Burlington Times-News. [read post]
9 May 2024, 9:32 am
This post summarizes the published criminal opinions from the North Carolina Court of Appeals released on May 7, 2024. [read post]
4 Apr 2019, 4:52 am
United States Department of Interior (Gaming – Tribal Service Area)Gibbs v. [read post]
27 Mar 2015, 8:44 am
North Carolina 14-593Issue: Whether the state of North Carolina performs an unconstitutional search when it requires a citizen to wear a GPS monitoring ankle bracelet for the rest of his life based only on the citizen's status as a recidivist sex offender and where there is no finding that he is a threat to society. [read post]
15 Apr 2009, 4:44 am
Metro-North Commuter Railroad Co. v. [read post]
2 Jun 2010, 6:55 am
North Carolina—see Constitutional Law Prof Blog (Levin), the Raleigh News & Observer (Alabama), and Courthouse News Service (both). [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
